Recently, combined treatment of a CRC mouse model with epithelial cell adhesion molecule (EpCAM)-CAR-NK-92 and regorafenib (a sorafenib-related multikinase inhibitor) achieved a synergistic tumor suppression than either treatment alone (140). Here, EPCAM is linked to colorectal carcinoma.